

Healthcare policy changes and renewed trade disruptions are creating a complex compliance environment for pharmaceutical and chemical companies. Procurement and compliance teams should prepare for simultaneous regulatory, logistics and supply chain challenges.

US industrial policy continues to evolve alongside environmental regulation. This article explains how the One Big Beautiful Bill Act fits into the broader policy environment influencing chemical manufacturing, investment planning and regulatory compliance.

Asian petrochemical producers are reshaping their naphtha sourcing strategies after major supply disruptions exposed concentration risks. This analysis explains why diversified procurement has become a long-term competitive advantage for buyers across the region.

India duty waiver expiry is creating urgent decisions for chemical importers and manufacturers as the customs exemption deadline approaches. Buyers must assess possible cost increases across key petrochemical products and adjust Q3 sourcing strategies.

MSG pricing is set for a pivotal shift as Chinese producers Fufeng Group and Meihua Holdings release their H2 2026 contracts. With stable corn costs and easing freight rates, the new price points could redefine global food ingredient procurement. This article explores the strategic moves of these key players and the competitive implications for buyers worldwide.

The EPA’s July 7 PFAS hearings will shape the regulatory landscape for the food industry. Chemical buyers must understand how differing US and EU rules influence H2 2026 sourcing of key ingredients such as citric acid, sucralose, and corn starch. Early action can secure supply and compliance.
We're committed to your privacy. Tradeasia uses the information you provide to us to contact you about our relevant content, products, and services. For more information, check out our privacy policy.